Sign In

Emily Blennerhassett

Interim Chief Executive Officer at Asthma Society of Ireland/Business Consultant

Emily Blennerhassett is a highly accomplished professional with a background in the pharmaceutical industry and healthcare sector.

She pursued her academic excellence at Ucd Michael Smurfit Graduate Business School, where she honed her business and leadership skills.

With extensive experience at AstraZeneca Pharmaceuticals, Emily held pivotal roles including Business Unit Director - Respiratory and Head of Commercial (Respiratory), showcasing her proficiency in respiratory healthcare.

Her contributions extended to the role of Hospital Business Manager at AstraZeneca Pharmaceuticals before she transitioned to broader leadership as the Interim Chief Executive Officer at the Asthma Society of Ireland.

Emily Blennerhassett's career trajectory exemplifies a commitment to improving patient outcomes and driving strategic growth within healthcare organizations.

Related Questions

What are Emily Blennerhassett's main responsibilities as Interim CEO at the Asthma Society of Ireland?
How did Emily Blennerhassett transition from pharmaceutical consulting to leading the Asthma Society of Ireland?
What initiatives has Emily Blennerhassett implemented at the Asthma Society of Ireland?
How has Emily Blennerhassett's background in pharmaceutical consulting influenced her approach at the Asthma Society of Ireland?
What are the key challenges Emily Blennerhassett faces as Interim CEO at the Asthma Society of Ireland?
Emily Blennerhassett
Emily Blennerhassett, photo 1
Emily Blennerhassett, photo 2
Add to my network

Location

Ireland